APA

Okamoto S., Matsuoka S., Takenaka N., Haredy A. M., Tanimoto T., Gomi Y., Ishikawa T., Akagi T., Akashi M., Okuno Y., Mori Y. & Yamanishi K. (20121024). Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. : Clinical and vaccine immunology : CVI.

Chicago

Okamoto Shigefumi, Matsuoka Sumiko, Takenaka Nobuyuki, Haredy Ahmad M, Tanimoto Takeshi, Gomi Yasuyuki, Ishikawa Toyokazu, Akagi Takami, Akashi Mitsuru, Okuno Yoshinobu, Mori Yasuko and Yamanishi Koichi. 20121024. Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. : Clinical and vaccine immunology : CVI.

Harvard

Okamoto S., Matsuoka S., Takenaka N., Haredy A. M., Tanimoto T., Gomi Y., Ishikawa T., Akagi T., Akashi M., Okuno Y., Mori Y. and Yamanishi K. (20121024). Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. : Clinical and vaccine immunology : CVI.

MLA

Okamoto Shigefumi, Matsuoka Sumiko, Takenaka Nobuyuki, Haredy Ahmad M, Tanimoto Takeshi, Gomi Yasuyuki, Ishikawa Toyokazu, Akagi Takami, Akashi Mitsuru, Okuno Yoshinobu, Mori Yasuko and Yamanishi Koichi. Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. : Clinical and vaccine immunology : CVI. 20121024.